Personal Details: First Name: Shahnaz Surname: Sali Date of Birth: 6 th September 1968 Place of Birth: Arak. Marital Status: Married, one son

Size: px
Start display at page:

Download "Personal Details: First Name: Shahnaz Surname: Sali Date of Birth: 6 th September 1968 Place of Birth: Arak. Marital Status: Married, one son"

Transcription

1 Personal Details: First Name: Shahnaz Surname: Sali Date of Birth: 6 th September 1968 Place of Birth: Arak Marital Status: Married, one son Work Address: Labbafinejad Hospital, 9 th Boostan Pasdaran St, Tehran, Iran Work Tel/fax: Address: dr.shsali@gmail.com Special Interest: Carrying research and compose medical/scientific papers Current Position: Associate Professor in infectious disease PROFILE: In depth leading knowledge of viral hepatitis & liver diseases, Tuberculosis, antibiotic stewardship and Nosocomial infections. "Hands on" practical medical skills on liver biopsy and other infectious diseases experiences and management of training department at Tehran Social Security Organization. Successfully passed many management training courses. Keen to elaborate on such issues as acute and chronic liver diseases, in particular viral hepatitis diagnosis and management, investigate on pulmonary and extra pulmonary tuberculosis. Has been an active reviewer of reputable local and international Page 1 of 11

2 journals. Managed to achieve top 10 reviewers (4 th position) at Hepatitis Monthly Journal. Quite skilled with general/medical computer software. EDUCATION: General Practitioner - Shahid Beheshti University of Medical Sciences, Tehran, Iran Infectious Diseases Specialist- Shahid Behsheti University of Medical Sciences,Tehran, Iran MPH- Tehran University of Medical Sciences, Tehran, Iran Research and clinical Observer- Barts and The London School of Medicine, London, United Kingdom. CURRENT STATUS: 2011 Sept 2016 July. Assistant Professor- Shahid Beheshti University of Medical Sciences, Tehran, Iran July- Present Associate Professor- Shahid Beheshti University of Medical Sciences, Tehran, Iran Present Member of Infectious Disease and Tropical Medicine Research Centre; Shahid Beheshti University of Medical Sciences, Tehran, Iran. AFFILIATED: Present Member of Tehran Hepatitis Center. Page 2 of 11

3 2011- Present Member of Global Hepatitis Network Present Active Reviewer- Hepatitis Monthly Journal WORK EXPERIENCE: Infectious Disease Specialist- Hepatitis B Consultant, Social Security of Iran. -Receiving patients with infectious Disease Complaints. - Providing Consultation to Liver Disease related patients. - Carrying out Liver Biopsy for patients with liver related diseases. - Giving consultation to families who may have a liver related disease. - Managed to bring together records and some statistics of patient with liver disease in social security Training Manager- Social Security of Tehran Province, Tehran, Iran. -Design and implement on the job training for Medical Doctors, Managers, Supervisors and other higher ranked personnel of Tehran Province Social Security. - Evaluate and assess personnel receiving on the job training and issue performance certificate. Page 3 of 11

4 - Design and implement various specialty workshops for various groups of personnel Infectious Diseases Consultant- Milad Specialized Hospital, Tehran, Iran. -Providing consultant to various wards. - Attending daily out-patient clinics and visiting patients. - Providing specialized liver diseases and viral hepatitis consultation and Carry out liver biopsy, where applicable Medical Resident- Shahid Labbafinejad Hospital, an affiliate of Shahid Beheshti University of Medical Sciences. - Being in charge of Infectious Disease Ward at different working shifts. - Supervising Stagers and other university students receiving trainings. - Visiting admitted patients at Infectious Diseases Ward. - Providing Infectious Diseases Consultation to different wards. - Visiting patients at the outpatient Department. ACHIEVEMENTS - Gained invaluable experience for management of illness. - Developed my skills in preparation of papers and research reports. Page 4 of 11

5 ORAL PAPERS PRESENTED: 1. Some Cases of Misdiagnosis of Hepatitis ; The 8 th Iranian Congress on Infectious Disease and Tropical Medicine, January Handling HCV Patients ; The 8 th Iranian Congress on Infectious Disease and Tropical Medicine, January Approach to Chronic HBV and HCV ; Re-training Seminar on Hepatitis, Karaj District, Iran, November Thalassemia Profile with HCV Infection ; Hepatitis and Special Diseases Seminar, February Reviewing Hepatitis B and C Virus in Karaj City ; Hepatitis, Prophylaxis and Treatment Seminar, November Indication and Complication of Liver Biopsy in Chronic Viral Hepatitis in Karaj ; Chronic Hepatitis, Prophylaxis and Treatment Seminar, July Relation Between Laboratory Test Result and Histological Hepatitis Activity in Individuals with Hepatitis C Virus ; The 13 th Iranian Congress on Infectious Disease and Tropical Medicine, December Prediction of Liver Histological lesions with Biochemical in-patients with Chronic Hepatitis B ; The 13 th Iranian Congress on Infectious Disease and Tropical Medicine, December Page 5 of 11

6 9. Chronic HBV and need for Patients Education Program (PEP) ; Review of Latest Viral Hepatitis Patients Management. December Prediction value Histological Activity induced with LFT and viral load in Chronic Hepatitis B ; The 14 th Iranian Congress on Infectious Disease and Tropical Medicine, January Levamizol does not enhance protective Ab response to HBV vaccination in hemodialysis patients population with a high response rate to routine vaccination ; IDRC Shahid Beheshti University of Medical Sciences, December Prevention and transmission of viral Hepatitis ; Milad Hospital, Viral Hepatitis Seminar, November Effect of Levamizole on HBV Vaccine in Hemodialysis Patients, International Internal Medicine Congress, December "Effect of HBV genetic diversity on outcome and prognosis chronic hepatitis B", 3rd Tehran Hepatitis Congress, "Survival Of Chronic HBV In Iran", 4 th Tehran Hepatitis Congress, Nov "Association Of IL28 B Polymorfism And HCV Core70 Amino Acid Substitution In Chronic Hepatitis C Patients", 4 th Tehran Hepatitis Congress, Nov Page 6 of 11

7 17. "Chronic Hepatitis C, Genotype, Metabolic Disorder and BMI: An Iranian Case Series", 5 th Tehran Hepatitis Congress, May "HBV Vaccine Escape Mutation Among Family Members Of Chronic Hepatitis B", 5 th Tehran Hepatitis Congress, May "The Role of Serum HBSAg Concentration and HBV DNA Level in Clinical, 5 th Tehran Hepatitis Congress, May Approach to Chronic HBV,6 th Tehran Hepatitis Congress, April CVC Infection in HD,Diagnosis & Management,Infection in Hemodialysis and Kidney Transplantation Congress,Feb Viral Hepatitis in Hemodialysis and Kidney Transplantation,International Urology and Nephrology Congress,Jul PUBLISHED PAPERS: 1. Reviewing Hepatitis C and Handling the Patients ; Review Article, The Islamic Republic of Iran Medical Authorities Magazine, December Interferon 2 b (PD feron B) in Treatment of HBeAg - Chronic Hepatitis B ; Hepatitis Monthly, Vol. 4, June Risk factors in chronic Hepatitis B infection Hepatitis Monthly, 5(4): Page 7 of 11

8 4- HBV Vaccination in chronic Renal Failure Patients Hepatitis Monthly, 6(1): Real Response to therapy in Chronic Hepatitis C Virus Patients : A Study From Iran ; Hepatitis Monthly (9): e A rare case presentation of oral actinomycosis, Iranian Journal of Mycobacteriology, June HIV and Viral Hepatitis (B,D,C) Co-Infection,Genotyping, Epidemiological Profile in West of Tehran ; Sextrans, May doi: /sextrans Influencing Factors on the Outcome and Prognosis of Patients With HBV Infction: Seven Years Follow-up ; Hepatitis Monthly Jul; 13(7): e Occupational Exposure to Blood Borne Viruses Among Healthcare Workers in a Tertiary Care Referral Hospital in Tehran ; Hepatitis Monthly Jul; 13(7): e Non-Invasive Histologic Markers of Liver Disease in Patients With Chronic Hepatitis B ; Hepatitis Mon February; 14(2): e Can Serum Level of HBsAg Differentiate HBeAg-negative Chronic Hepatitis B from Inactive Carrier State? ; Diagnostic Microbiology and Infectious Diseases February; in press. 12- An Unusual Presentation of Tuberculous Meningitis ; Arch Clin Infect Dis July; 10(3): e Seroclearance of Hbsag in Chronic Hepatitis B Virus Patients on Lamivudine Therapy: A 10 Year Experience ; Global Journal of Health Science; Vol. 7, No. 6; Page 8 of 11

9 14- Multiple Intracranial Tuberculomas in a Post-Kidney Transplant Patient ; Saudi J Kidney Dis Transpl 2016;27(1): Association of Plasma Levels of Vitamin D With Chronic Hepatitis B Infection ; Hepat Mon January; 16(1): e Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: AComprehensive Review- Screened ; Hepat Mon April; 16(4):e Tumor Necrosis Factor 308 G/A Polymorphisms and Risk of Hepatocellular Carcinoma: A Meta-Analysis ; Hepat Mon April; 16(4):e Outcome of Accidental Exposure Prone to Blood Borne Viral Infections in an Educational Hospital ; Novelty in Biomedicine, Received: 15 November, 2015; Accepted: 11 January, Manipulation of Regulatory Cells Responses to Treatments for Chronic Hepatitis B Virus Infection ; Hepat Mon. In Press(In Press):e A case of endocarditis presenting with icterus ; Sch J Med Case Rep 2016; 4(6): THESIS SUPERVISOR: General Practitioner s Thesis Supervisor: 1- Economical estimation of Streptococcal pharyngitis and strategic analysis for determining its diagnosis treatment in Iran. Vahid Shahkarami, Infectious Diseases Specialist Thesis Supervisor: 1- Phylogenic intra familial analysis of HBV amongst Labbafinejad Hospital Outpatient Clinic. Shirin Azarmanesh, The outcome of HBV inactive carrier state amongst Iranian patients in a 10 years period. Zahra Seghatoleslam, Page 9 of 11

10 3- Investigating mutation related to Gancyclovir resistance within UL 97 of CMV amongst Iranian kidney transplantation infected with CMV under Gancyclovir therapy at Labbfinejad Hospital, Farhad Soori, Investigation on anti-biotic resistance pattern and bacterial infection risk factors amongst kidney transplant patients at Labbfinejad Hospital during 2014 and 2015, Marjan Hemmatian. 5- Investigating distribution of risk factors of chronic hepatitis C among patients visiting Labbafinejad Hospital during 2014 and 2015, Marziyeh Ashrafi Chalan Olia. 6- Evaluating 53 cases of HBV Cirrhosis at Labbafinejad Hospital, Farazam Quicky, HONORS ACHIEVED: I was awarded top researcher during 6 th Research Festival of Shahid Beheshti University of Medical Sciences TRAINING COURSES/WORKSHOPS: 1. Introduction to ISO (Training); TUV Academy. 2. Internal Quality Audit based on Requirements of ISO 9000:2000; TUV Academy. 3. Strategic Management. 4. Problem Solving. 5. Human Resources. 6. Stress Management. 7. Change Management. 8. Evaluation Management. 9. Management Information Systems Management of Health Centers and Organizations Research Workshop: Techniques for preparation of Proposals, Advance Methodology and Search Strategy, etc. Page 10 of 11

11 PROFESSIONAL COURSES/WORKSHOPS: 1. Lesson Plans. 2. Teaching Methods. 3. Clinical Teaching. 4. Student Evaluation Techniques. 5. Professional Ethics. 6. Terminology in Medical Education. BOOKS PUBLISHED: 1. Chronic Viral Hepatitis C; Summer Practical Approach to Viral hepatitis; summer Page 11 of 11

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice SCOPE Clinical guideline title: Hepatitis B (chronic): diagnosis and management of chronic hepatitis B in children, young

More information

CITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE

CITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE CITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE Chronic Hepatitis B virus (HBV) is an important public health problem globally and a leading cause of liver

More information

EAST LONDON INTEGRATED CARE

EAST LONDON INTEGRATED CARE CITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE Chronic Hepatitis B virus (HBV) is an important public health problem globally and a leading cause of liver

More information

Curriculum Vitae. Personal Background: In The Name of GOD. Surname:Ghadimimoghadam. Forename: Abdolkarim. Date of Birth: June,22,1968

Curriculum Vitae. Personal Background: In The Name of GOD. Surname:Ghadimimoghadam. Forename: Abdolkarim. Date of Birth: June,22,1968 In The Name of GOD Curriculum Vitae Personal Background: Surname:Ghadimimoghadam Forename: Abdolkarim Date of Birth: June,22,1968 Place of Birth: Bushehr,Iran Sex: Male Marital Status: Married No. of children:

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice SCOPE Clinical guideline title: Hepatitis B (chronic): diagnosis and management of chronic hepatitis B in children, young

More information

Management of Hepatitis B - Information for primary care providers

Management of Hepatitis B - Information for primary care providers Management of Hepatitis B - Information for primary care providers July 2018 Chronic hepatitis B (CHB) is often a lifelong condition. Not everyone infected needs anti-viral therapy. This document outlines

More information

Management of HBV in KidneyTransplanted Patients Dr.E.Nemati

Management of HBV in KidneyTransplanted Patients Dr.E.Nemati Management of HBV in KidneyTransplanted Patients Dr.E.Nemati Hepatitis B virus (HBV) infection Hepatitis B virus (HBV) infection confers a significantly negative impact on the clinical outcomes of kidney

More information

Hepadnaviridae family (DNA) Numerous antigenic components Humans are only known host May retain infectivity for more than 7 days at room temperature

Hepadnaviridae family (DNA) Numerous antigenic components Humans are only known host May retain infectivity for more than 7 days at room temperature Hepatitis B Epidemic jaundice described by Hippocrates in 5th century BC Jaundice reported among recipients of human serum and yellow fever vaccines in 1930s and 1940s Australia antigen described in 1965

More information

ELPA S VISION OF SCREENING

ELPA S VISION OF SCREENING ELPA S VISION OF SCREENING By Nadine Piorkowsky President of the European Liver Patients Association, Budapest, 18-19 March 2010 ELPA s network The Patient s View a viral time bomb: Up to 9 out of 10 chronic

More information

Viral hepatitis Blood Born hepatitis. Dr. MONA BADR Assistant Professor College of Medicine & KKUH

Viral hepatitis Blood Born hepatitis. Dr. MONA BADR Assistant Professor College of Medicine & KKUH Viral hepatitis Blood Born hepatitis Dr. MONA BADR Assistant Professor College of Medicine & KKUH Outline Introduction to hepatitis Characteristics of viral hepatitis Mode of transmission Markers of hepatitis

More information

Health Care Workers and Viral Hepatitis in Turkey. Bulent Degertekin M.D. Viral Hepatitis Prevention Board Meeting

Health Care Workers and Viral Hepatitis in Turkey. Bulent Degertekin M.D. Viral Hepatitis Prevention Board Meeting Different Aspects of Viral Hepatitis Health Care Workers and Viral Hepatitis in Turkey Bulent Degertekin M.D. Viral Hepatitis Prevention Board Meeting 12 13 November 2009 Istanbul. Turkey Hepatitis B and

More information

Time to Eliminate Hepatitis B John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention

Time to Eliminate Hepatitis B John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention Time to Eliminate Hepatitis B John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention Division of Viral Hepatitis National Center for HIV/AIDS, Viral Hepatitis, STD, and

More information

Viral Hepatitis. Dr Melissa Haines Gastroenterologist Waikato Hospital

Viral Hepatitis. Dr Melissa Haines Gastroenterologist Waikato Hospital Viral Hepatitis Dr Melissa Haines Gastroenterologist Waikato Hospital Viral Hepatitis HAV HBV HCV HDV HEV Other viral: CMV, EBV, HSV Unknown Hepatitis A Hepatitis A Transmitted via the faecal-oral route

More information

Viral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a

Viral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a Viral hepatitis Supervised by: Dr.Gaith presented by: Shaima a & Anas & Ala a Etiology Common: Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Less common: Cytomegalovirus EBV Rare: Herpes

More information

The Hepatitis B-e antigen-positive

The Hepatitis B-e antigen-positive The Hepatitis B-e antigen-positive Dental Student Developing an Equitable Policy Hepatitis B Virus Serology 1 HBsAg A protein on the surface of HBV; it can be detected in high levels in serum during acute

More information

Hepatitis B Virus. Taylor Page PharmD Candidate 2019 February 1, 2019

Hepatitis B Virus. Taylor Page PharmD Candidate 2019 February 1, 2019 Hepatitis B Virus Taylor Page PharmD Candidate 2019 February 1, 2019 Epidemiology 3218 cases of acute HBV reported in 2016 847,000 non-institutionalized persons living with chronic HBV in 2011-2012 Viral

More information

Viral Hepatitis Diagnosis and Management

Viral Hepatitis Diagnosis and Management Viral Hepatitis Diagnosis and Management CLINICAL BACKGROUND Viral hepatitis is a relatively common disease (25 per 100,000 individuals in the United States) caused by a diverse group of hepatotropic agents

More information

Seroprevalence of Hepatitis A in Hemodialysis Patient Candidate for Kidney Transplant Younger Than Forty Years

Seroprevalence of Hepatitis A in Hemodialysis Patient Candidate for Kidney Transplant Younger Than Forty Years Novelty in Biomedicine Original Article Seroprevalence of Hepatitis A in Hemodialysis Patient Candidate for Kidney Transplant Younger Than Forty Years Sara Abolghasemi 1, Shahnaz Sali 1, Ensieh Arabsaghari

More information

Chronic hepatitis B virus (HBV)

Chronic hepatitis B virus (HBV) Chronic hepatitis B virus (HBV) Information for patients This leaflet explains chronic hepatitis B virus, including how you may have become infected, the main symptoms and how it is treated. If you have

More information

Outline. Updates in the Clinical Management of Hepatitis B and C. Who should be screened for HBV? Chronic Hepatitis B 10/7/2018

Outline. Updates in the Clinical Management of Hepatitis B and C. Who should be screened for HBV? Chronic Hepatitis B 10/7/2018 Outline Updates in the Clinical Management of Hepatitis B and C Jennifer C. Lai, MD, MBA Transplant Hepatologist Associate Professor of Medicine In Residence University of California, San Francisco Initial

More information

The ABCs of Viral Hepatitis Diagnosis. Ila Singh, M.D., Ph.D. P & S Viral Hepatitis. Hepatitis A, B, C, D, E and G viruses

The ABCs of Viral Hepatitis Diagnosis. Ila Singh, M.D., Ph.D. P & S Viral Hepatitis. Hepatitis A, B, C, D, E and G viruses The ABCs of Viral Hepatitis Diagnosis Ila Singh, M.D., Ph.D. P & S 14-453 is132@columbia.edu Viral Hepatitis Hepatotropic viruses Hepatitis A, B, C, D, E and G viruses Generalized infection plus infection

More information

S401- Updates in the Treatments of Hepatitis B & C

S401- Updates in the Treatments of Hepatitis B & C S401- Updates in the Treatments of Hepatitis B & C Ruben Gonzalez-Vallina, MD Director of Gastroenterology Outpatient Initiatives Miami Children s Hospital Miami, Florida Disclosure of Relevant Relationship

More information

Curriculum Vitae. Personal Information. In the name of God. First name: Zahra Last name: Shams Mofarahe

Curriculum Vitae. Personal Information. In the name of God. First name: Zahra Last name: Shams Mofarahe In the name of God Curriculum Vitae Personal Information First name: Zahra Last name: Shams Mofarahe Status: Assistant Professor of Department Biology and Anatomical Sciences Gender: Female Marital status:

More information

JMSCR Volume 03 Issue 01 Page January 2015

JMSCR Volume 03 Issue 01 Page January 2015 www.jmscr.igmpublication.org Impact Factor 3.79 ISSN (e)-2347-176x Seroprevalence of HBV among HIV Patients and Blood Donors Author Dr. Vedavati B I 1, Dr. Amrutha Kumari B 2, Dr. Venkatesha D 3 Mysore

More information

Update: ACIP Recommendations for Hepatitis B Vaccination

Update: ACIP Recommendations for Hepatitis B Vaccination National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Update: ACIP Recommendations for Hepatitis B Vaccination Sarah Schillie, MD, MPH, MBA Summit for the Elimination of Hepatitis B and

More information

CURRICULUM VITAE. National Board Certification in Pediatric Neurology, 2008

CURRICULUM VITAE. National Board Certification in Pediatric Neurology, 2008 CURRICULUM VITAE Sepideh Amouian: Child Neurologist, MD, First rank of Iranian National Board Certification in Pediatric Neurology, 2008 PERSONAL INFORMATION Name: Sepideh Amouian Sex: Female Date of birth:

More information

Hepatitis B: A Preventable Cause of Liver Cancer. Saira Khaderi MD, MPH Assistant Professor of Surgery Associate Director, Project ECHO June 17, 2016

Hepatitis B: A Preventable Cause of Liver Cancer. Saira Khaderi MD, MPH Assistant Professor of Surgery Associate Director, Project ECHO June 17, 2016 Hepatitis B: A Preventable Cause of Liver Cancer Saira Khaderi MD, MPH Assistant Professor of Surgery Associate Director, Project ECHO June 17, 2016 Overview Epidemiology HBV and cancer Screening, Diagnosis

More information

Hepatitis STARS Program. Geri Brown, M.D. Associate Professor Department of Internal Medicine October 4, 2003

Hepatitis STARS Program. Geri Brown, M.D. Associate Professor Department of Internal Medicine October 4, 2003 Hepatitis 2003 STARS Program Geri Brown, M.D. Associate Professor Department of Internal Medicine October 4, 2003 Outline n Hepatitis A Epidemiology and screening Transmission n Hepatitis B Epidemiology

More information

Hepatitis C Virus (HCV): Current Screening Guidelines and Treatment Approaches

Hepatitis C Virus (HCV): Current Screening Guidelines and Treatment Approaches Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/hepatitis-c-virus-hcvcurrent-screening-guidelines-treatment-approaches/9514/

More information

The Alphabet Soup of Viral Hepatitis Testing

The Alphabet Soup of Viral Hepatitis Testing The Alphabet Soup of Viral Hepatitis Testing August 18, 2011 Patricia Slev, PhD, DABCC Medical Director, Serologic Hepatitis and Retrovirus Laboratory, ARUP Laboratories Assistant Professor of Pathology,

More information

Learning Objectives: Hepatitis Update. Primary Causes of Chronic Liver Disease in the U.S. Hepatitis Definition. Hepatitis Viruses.

Learning Objectives: Hepatitis Update. Primary Causes of Chronic Liver Disease in the U.S. Hepatitis Definition. Hepatitis Viruses. Learning Objectives: Hepatitis Update ASCLS-Michigan March 31, 2016 Dr. Kathleen Hoag Upon attendance of this seminar and review of material provided, the attendees will be able to: 1. List hepatitis viruses

More information

Epidemiology and Screening for Hepatitis C Infection

Epidemiology and Screening for Hepatitis C Infection Epidemiology and Screening for Hepatitis C Infection Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology Epidemiology/Screening for Hepatitis

More information

Intron A Hepatitis B. Intron A (interferon alfa-2b) Description

Intron A Hepatitis B. Intron A (interferon alfa-2b) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.01.01 Subject: Intron A Hepatitis B Page: 1 of 7 Last Review Date: November 30, 2018 Intron A Hepatitis

More information

patients with blood borne viruses Controlled Document Number: Version Number: 4 Controlled Document Sponsor: Controlled Document Lead:

patients with blood borne viruses Controlled Document Number: Version Number: 4 Controlled Document Sponsor: Controlled Document Lead: CONTROLLED DOCUMENT Procedure for the management of patients with blood borne viruses CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Version Number: 4 Controlled Document Sponsor: Controlled

More information

CURRICULUM VITAE MOSTAFA BAHREMAND

CURRICULUM VITAE MOSTAFA BAHREMAND CURRICULUM VITAE MOSTAFA BAHREMAND Personal Information Name: Mostafa Bahremand Birth: 25-6-1973,Khoy,Iran Scientific Degree: Assistant professor of cardiology in kermanshah university of medical science

More information

Epidemiology of HCV infection among HD pts in Iran and prevention strategies

Epidemiology of HCV infection among HD pts in Iran and prevention strategies Epidemiology of HCV infection among HD pts in Iran and prevention strategies B. Einollahi Professor of Internal Medicine/Nephrology Division Baqiyatallah University of Medical Sciences 4th International

More information

Management of Chronic Hepatitis B in Asian Americans

Management of Chronic Hepatitis B in Asian Americans Management of Chronic Hepatitis B in Asian Americans Myron J Tong; UCLA, CA Calvin Q. Pan; Mount Sinai, NY Hie-Won Hann; Thomas Jefferson, PA Kris V. Kowdley; Virginia Mason, WA Steven Huy B Han; UCLA,

More information

Evaluation of Hepatitis B Vaccination Efficiency among Health Care Workers in West of Iran. Farajolah Maleki 2 **

Evaluation of Hepatitis B Vaccination Efficiency among Health Care Workers in West of Iran. Farajolah Maleki 2 ** Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2017, 9 [5]:29-34 [http://scholarsresearchlibrary.com/archive.html] ISSN 0975-5071 USA CODEN: DPLEB4

More information

Il trapianto di cellule staminali emopoietiche nel paziente portatore di virus epatitici

Il trapianto di cellule staminali emopoietiche nel paziente portatore di virus epatitici Il trapianto di cellule staminali emopoietiche nel paziente portatore di virus epatitici Anna Locasciulli Ematologia e Trapianto di Cellule Staminali Emopoietiche Ospedale S.Camillo, Roma Il trapianto

More information

Toronto Declaration: Strategies to control and eliminate viral hepatitis globally. A call for coordinated action

Toronto Declaration: Strategies to control and eliminate viral hepatitis globally. A call for coordinated action Toronto Declaration: Strategies to control and eliminate viral hepatitis globally A call for coordinated action Hepatitis B National Action Plan All countries should develop a national and/or regional

More information

ELIMINATION OF VIRAL HEPATITIS IN ROMANIA LESSONS LEARNT AND THE WAY FORWARD

ELIMINATION OF VIRAL HEPATITIS IN ROMANIA LESSONS LEARNT AND THE WAY FORWARD ELIMINATION OF VIRAL HEPATITIS IN ROMANIA LESSONS LEARNT AND THE WAY FORWARD 17 May 2018 Bucharest, Romania Organisers Associations Collaborating on Hepatitis to Immunize and Eliminate the Viruses in Europe

More information

HEPATITIS B MANAGEMENT

HEPATITIS B MANAGEMENT HEPATITIS B MANAGEMENT Background Chronic Hepatitis B Virus (HBV) infection had an estimated prevalence in Australia of 0.7-0.8% in 2002 (1). Prevalence is highest in people born in much of Asia and Africa

More information

Hepatitis B. What's the impact on the risk? Dr Himanshu Bhatia, Asia Chief Medical Officer ALUCA, Brisbane, Sept 2013

Hepatitis B. What's the impact on the risk? Dr Himanshu Bhatia, Asia Chief Medical Officer ALUCA, Brisbane, Sept 2013 Hepatitis B What's the impact on the risk? Dr Himanshu Bhatia, Asia Chief Medical Officer ALUCA, Brisbane, Sept 2013 Some quick facts about Hepatitis B Worldwide: 350-400 Million are chronic infections

More information

Hepatitis. Dr. Mohamed. A. Mahdi 5/2/2019. Mob:

Hepatitis. Dr. Mohamed. A. Mahdi 5/2/2019. Mob: Hepatitis Dr. Mohamed. A. Mahdi Mob: 0123002800 5/2/2019 Hepatitis Hepatitis means the inflammation of the liver. May cause by viruses or bacteria, parasites, radiation, drugs, chemical and toxins (alcohol).

More information

in pregnancy Document Review History Version Review Date Reviewed By Approved By

in pregnancy Document Review History Version Review Date Reviewed By Approved By GYNAECOLOGY/ ANTENATAL CARE WIRRAL WOMEN & CHILDREN S HOSPITAL Guideline No: Hepatitis B management in pregnancy VERSION 1 AMENDMENTS MADE: N/A DATE OF ISSUE: May 2012 DATE OF REVIEW: May 2015 REVIEW INTERVAL:

More information

Mazandaran University of Medical Sciences

Mazandaran University of Medical Sciences Mazandaran University of Medical Sciences Personal Information Roya Ghasemian Academic Rank : Assistant Professor of Infectious Disease Email : roya٣١gh {at} yahoo.com Address : Faculty of Medicine, Mazandaran

More information

Epidemiology of Hepatitis C Iran

Epidemiology of Hepatitis C Iran Seyed Moayed Alavian M.D. Professor of Gastro & Hepatology Editor-in-chief of Glob Hepat Comm Editor-in-chief of Hepatitis Monthly E mail: editor@hepatmon.com Epidemiology of Hepatitis C Iran Epidemiology

More information

TRANSMISSION OF BLOODBORNE PATHOGENS: HIV,HBV,HCV. Dr Daniel Kimani HIV Prevention Medical Transmission CDC, Kenya.

TRANSMISSION OF BLOODBORNE PATHOGENS: HIV,HBV,HCV. Dr Daniel Kimani HIV Prevention Medical Transmission CDC, Kenya. TRANSMISSION OF BLOODBORNE PATHOGENS: HIV,HBV,HCV Dr Daniel Kimani HIV Prevention Medical Transmission CDC, Kenya. Nevada Hepatitis C Outbreak Tied to Las Vegas Clinic. Thousands Now At Risk for Hepatitis,

More information

Natural History of Chronic Hepatitis B

Natural History of Chronic Hepatitis B Natural History of Chronic Hepatitis B Anna SF Lok, MD Alice Lohrman Andrews Professor in Hepatology Director of Clinical Hepatology Assistant Dean for Clinical Research University of Michigan Ann Arbor,

More information

The Early Results of a New Health Care Program Implementation in HBV Screening: an Iranian Experience

The Early Results of a New Health Care Program Implementation in HBV Screening: an Iranian Experience 228 Original Article The Early Results of a New Health Care Program Implementation in HBV Screening: an Iranian Experience Afsaneh Sharifian 1, Nostratollah Naderi 1*, Azar Sanati 2, Seyed Reza Mohebi

More information

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Emergency Department and Receiving Areas CHAPTER 24: Author P. Suri, MD R. Gopaul, MD

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Emergency Department and Receiving Areas CHAPTER 24: Author P. Suri, MD R. Gopaul, MD GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 24: Emergency Department and Receiving Areas Author P. Suri, MD R. Gopaul, MD Chapter Editor Gonzalo Bearman MD, MPH, FACP, FSHEA, FIDSA Topic Outline

More information

Hepatitis B screening and surveillance in primary care

Hepatitis B screening and surveillance in primary care Hepatitis B screening and surveillance in primary care Catherine Stedman Associate Professor of Medicine, University of Otago, Christchurch Gastroenterology Department, Christchurch Hospital Disclosures

More information

Viral Hepatitis. Background

Viral Hepatitis. Background Viral Hepatitis Background Hepatitis or inflammation of the liver can be caused by infectious and noninfectious problems. Infectious etiologies include viruses, bacteria, fungi and parasites. Noninfectious

More information

IN THE NAME OF GOD. D r. MANIJE DEZFULI AZAD UNIVERCITY OF TEHRAN BOOALI HOSPITAL INFECTIOUS DISEASES SPECIALIST

IN THE NAME OF GOD. D r. MANIJE DEZFULI AZAD UNIVERCITY OF TEHRAN BOOALI HOSPITAL INFECTIOUS DISEASES SPECIALIST IN THE NAME OF GOD AZAD UNIVERCITY OF TEHRAN BOOALI HOSPITAL D r. MANIJE DEZFULI INFECTIOUS DISEASES SPECIALIST Acute Viral Hepatitis The Anatomy of the Liver Hepatic Physiology Liver: Largest solid organ

More information

Hepatitis B in Africa: Epidemiology, Pathophysiology and Challenges

Hepatitis B in Africa: Epidemiology, Pathophysiology and Challenges Gilead-sponsored symposium at the 11th INTEREST Workshop 2017 Hepatitis B in Africa: Epidemiology, Pathophysiology and Challenges Ponsiano Ocama Department of Medicine Makerere University College of Health

More information

Consensus AASLD-EASL HBV Treatment Endpoint and HBV Cure Definition

Consensus AASLD-EASL HBV Treatment Endpoint and HBV Cure Definition Consensus AASLD-EASL HBV Treatment Endpoint and HBV Cure Definition Anna S. Lok, MD, DSc Alice Lohrman Andrews Professor in Hepatology Director of Clinical Hepatology Assistant Dean for Clinical Research

More information

Clinical Management of Hepatitis B WAN-CHENG CHOW DEPARTMENT OF GASTROENTEROLOGY & HEPATOLOGY SINGAPORE GENERAL HOSPITAL

Clinical Management of Hepatitis B WAN-CHENG CHOW DEPARTMENT OF GASTROENTEROLOGY & HEPATOLOGY SINGAPORE GENERAL HOSPITAL Clinical Management of Hepatitis B WAN-CHENG CHOW DEPARTMENT OF GASTROENTEROLOGY & HEPATOLOGY SINGAPORE GENERAL HOSPITAL The World Health Organisation recent initiatives on HBV infection Launching of the

More information

DEPARTMENT OF GENITO-URINARY MEDICINE HEPATITIS B

DEPARTMENT OF GENITO-URINARY MEDICINE HEPATITIS B DEPARTMENT OF GENITO-URINARY MEDICINE MAIN TRANSMISSION ROUTES HEPATITIS B Sexual transmission Occurs in unvaccinated/non immune men who have sex with men and correlates with multiple partners, unprotected

More information

Management of Hepatitis B

Management of Hepatitis B Management of Hepatitis B Background HBV is contracted either sexually or by blood to blood transmission. The combined prevalence of HBV and HCV is just over 2% in the UK. More than 95% of immune competent

More information

Molecular genetic characterization of hepatitis epidemiology in Latvia Irina Somiskaya Paul Pumpens

Molecular genetic characterization of hepatitis epidemiology in Latvia Irina Somiskaya Paul Pumpens Molecular genetic characterization of hepatitis epidemiology in Latvia Irina Somiskaya Paul Pumpens Riga 2015 Sequencing of viral genes and complete viral genomes Results in: identification of viral genotype/subtype/mutants

More information

Molina Healthcare of Texas Hepatitis C Drugs (Medicaid)

Molina Healthcare of Texas Hepatitis C Drugs (Medicaid) Texas Standard Prior Authorization Form Addendum Molina Healthcare of Texas Hepatitis C Drugs (Medicaid) This fax machine is located in a secure location as required by HIPAA Regulations. Complete / Review

More information

Hepatitis B: A Physician's Guide To The Disease And Its Associated Hepatitis B (Australia) Antigen By Sydney Kofman

Hepatitis B: A Physician's Guide To The Disease And Its Associated Hepatitis B (Australia) Antigen By Sydney Kofman Hepatitis B: A Physician's Guide To The Disease And Its Associated Hepatitis B (Australia) Antigen By Sydney Kofman If searched for the ebook Hepatitis B: A Physician's Guide to the Disease and Its Associated

More information

HEPATITIS B INFECTION and Pregnancy. Caesar Mensah Communicable Diseases & Infection Control Specialist, UK June 2011

HEPATITIS B INFECTION and Pregnancy. Caesar Mensah Communicable Diseases & Infection Control Specialist, UK June 2011 HEPATITIS B INFECTION and Pregnancy Caesar Mensah Communicable Diseases & Infection Control Specialist, UK June 2011 HEPATITIS B 26/07/2011 What is Hepatitis B? It is inflammation (infection) of the liver

More information

Indian Journal of Basic and Applied Medical Research; June 2016: Vol.-5, Issue- 3, P

Indian Journal of Basic and Applied Medical Research; June 2016: Vol.-5, Issue- 3, P Original article: Comparative study on Prevalence of Hepatitis B surface antigen among blood donors and In patient hospital attendees at a tertiary care hospital, Hyderabad. 1Dr M. Khaleel, 2 Dr Ameena

More information

CV Form. marzieh Nikparvar

CV Form. marzieh Nikparvar CV Form marzieh Nikparvar Assistant Professor, Department of Cardiology, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, IRAN CV (Curriculum Vitae) Last updated nov, 2013 1

More information

EXPOSURE (HIV/HEPATITIS) BLOOD & BODY FLUIDS

EXPOSURE (HIV/HEPATITIS) BLOOD & BODY FLUIDS Page(s): 1 of 11 PURPOSE To set a standardized procedure to ensure that employees are evaluated in a consistent and timely manner.. POLICY A. The treatment of Team Member exposure to bloodborne pathogens

More information

Student Immunisation Record Faculty of Medicine. Section 1: Information. Notes

Student Immunisation Record Faculty of Medicine. Section 1: Information. Notes Student Immunisation Record Faculty of Section 1: Information Students enrolled in programs offered by the Faculty of are REQUIRED to provide evidence of their immunisation status for the diseases listed

More information

Management of Patients with Chronic Hepatitis B: The Alaska Experience

Management of Patients with Chronic Hepatitis B: The Alaska Experience Management of Patients with Chronic Hepatitis B: The Alaska Experience Brian J McMahon, MACP, FAASLD Liver Disease and Hepatitis Program Alaska Native Tribal Health Consortium Disclosures I have no conflicts

More information

PERINATAL HEPATIDES AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) Pamela Palasanthiran Staff Specialist, Paediatric Infectious Diseases

PERINATAL HEPATIDES AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) Pamela Palasanthiran Staff Specialist, Paediatric Infectious Diseases PERINATAL HEPATIDES AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) Pamela Palasanthiran Staff Specialist, Paediatric Infectious Diseases Viruses in July (ViJ), 2004 Overview Epidemiology Perinatal transmission

More information

Hepatitis B Update. Jorge L. Herrera, M.D. University of South Alabama Mobile, AL. Gastroenterology

Hepatitis B Update. Jorge L. Herrera, M.D. University of South Alabama Mobile, AL. Gastroenterology Hepatitis B Update Jorge L. Herrera, M.D. University of South Alabama Mobile, AL Deciding Who to Treat Is hepatitis B a viral disease or a liver disease? Importance of HBV-DNA Levels in the Natural History

More information

Cedars Sinai Medical Center Pediatric Electives

Cedars Sinai Medical Center Pediatric Electives PE 235.03 MEDICAL GENETICS COURSE CHAIR: John M. Graham, M.D., ScD.. By arrangement - Please contact the Student Coordinator 1. Counseling techniques and the approach to the patient and family with hereditary

More information

Patient Name: MRN: DOB: Treatment Location:

Patient Name: MRN: DOB: Treatment Location: Page 1 of 5 I. TO (Required) This Section is required to be completed by all patients who undergo kidney transplant surgery. I hereby consent to and authorize Dr. and his/her assistant(s), including supervised

More information

casebasedhepatitis bmanagement Management of Hepatitis B: A Case-based Approach

casebasedhepatitis bmanagement Management of Hepatitis B: A Case-based Approach casebasedhepatitis bmanagement Management of Hepatitis B: A Case-based Approach In order to receive credit for this activity, please complete the post-test by recording the best answer to each question

More information

2016: The State of HIV & Hepatitis C in the District

2016: The State of HIV & Hepatitis C in the District 2016: The State of HIV & Hepatitis C in the District Travis A. Gayles, MD, PhD Chief Medical Officer, HIV/AIDS, Hepatitis, STD, and TB Administration Division Chief, STD and TB Control February 29, 2016

More information

A VIEW OF DEMOGRAPHIC FACTORS OF HEPATITIS B VIRUS INFECTION IN DURRES REGION DURING

A VIEW OF DEMOGRAPHIC FACTORS OF HEPATITIS B VIRUS INFECTION IN DURRES REGION DURING Interdisplinary Journal of Research and Development Alexander Moisiu University, Durrës, Albania Vol (IV), No.2, 2017 Paper presented in 1 -st International Scientific Conference on Professional Sciences,

More information

Title: Reactivation of a Hepatitis B without core antibody: a case report.

Title: Reactivation of a Hepatitis B without core antibody: a case report. JCM Accepted Manuscript Posted Online 28 January 2015 J. Clin. Microbiol. doi:10.1128/jcm.03546-14 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 1 Title: Reactivation of a Hepatitis

More information

Knowledge, attitude and practices among health care workers on needle-stick injuries

Knowledge, attitude and practices among health care workers on needle-stick injuries Kathmandu University Medical Journal (2003) Vol. 1,. 2, 91-94 Original Article Knowledge, attitude and practices among health care workers on needle-stick injuries Gurubacharya DL 1, KC Mathura 2, Karki

More information

B B (P 0/05) . High-risk. ( )..

B B (P 0/05) . High-risk. ( ).. : 3 2 1 B : B. B. : 76.. ELISA B. 86/8 6/6 6/6 : B. B (P 0/05) (100> B ).. High-risk. B : 1 firozzadfatah@gmail.com ( ).. 2.. 3.. ١ Postvaccination Hepatitis B Antibody titer on students of Ardebil College

More information

Test Name Results Units Bio. Ref. Interval

Test Name Results Units Bio. Ref. Interval LL - LL-ROHINI (NATIONAL REFERENCE 135091650 Age 49 Years Gender Male 29/8/2017 120000AM 29/8/2017 100248AM 29/8/2017 105306AM Ref By Final HEATITIS, VIRAL, COMREHENSIVE ANEL HEATITIS A ANTIBODY (ANTI

More information

Mutants and HBV vaccination. Dr. Ulus Salih Akarca Ege University, Izmir, Turkey

Mutants and HBV vaccination. Dr. Ulus Salih Akarca Ege University, Izmir, Turkey Mutants and HBV vaccination Dr. Ulus Salih Akarca Ege University, Izmir, Turkey Geographic Distribution of Chronic HBV Infection 400 million people are carrier of HBV Leading cause of cirrhosis and HCC

More information

Overview of Blood Transfusion System of Iran:

Overview of Blood Transfusion System of Iran: Report Article Overview of Blood Transfusion System of Iran: 2002-2011 AM Cheraghali High Institute for Research and Education on Transfusion Medicine, Iran Blood Transfusion Organization and University

More information

Identification and management of chronic viral hepatitis in Russia

Identification and management of chronic viral hepatitis in Russia Technical Viral Hepatitis Prevention Board Meeting IDENTIFICATION AND MANAGEMENT OF PERSONS WITH CHRONIC VIRAL HEPATITIS IN EUROPE Budapest, Hungary, March 18-19, 21 Identification and management of chronic

More information

Prevent Hepatocellular Carcinoma through Screening, Vaccination, and Treatment of Viral Hepatitis Milena Gould Suarez, MD

Prevent Hepatocellular Carcinoma through Screening, Vaccination, and Treatment of Viral Hepatitis Milena Gould Suarez, MD Prevent Hepatocellular Carcinoma through Screening, Vaccination, and Treatment of Viral Hepatitis Milena Gould Suarez, MD Hello, my name is Milena Gould Suarez, and today I will present "Prevent Hepatocellular

More information

Curriculum Vitae Saeed Nemati,D.D.S

Curriculum Vitae Saeed Nemati,D.D.S Curriculum Vitae Saeed Nemati,D.D.S Address: E-mail: Publication Center,, Central Building, Zand St. Shiraz, Iran P.O.Box: 71345-1878 Tele Fax:+98-711- 2351865 (Work) Tel:+98-711-2339830 (Private Practice)

More information

Academic Qualifications

Academic Qualifications Vitae Dr. Nooshin Parvaresh Office address : Shahid Beheshti Hospital, Kerman, IRAN Office Phone : 98 341 2116328 Mobile : 98 913 341 5627 E-mail : n _ parvaresh @ yahoo.com Personal Details Surname :

More information

Curriculum Vitae. Department of Anesthesiology, Shahid Beheshti University of Medical Sciences ( UMS ), Emam Hossein Hospital, Tehran, IRAN.

Curriculum Vitae. Department of Anesthesiology, Shahid Beheshti University of Medical Sciences ( UMS ), Emam Hossein Hospital, Tehran, IRAN. Dr Mehran KOUCHEK Curriculum Vitae Department of Anesthesiology, Shahid Beheshti University of Medical Sciences ( UMS ), Emam Hossein Hospital, Tehran, IRAN. Date of birth : 52 December 9121 Place of birth

More information

Non-Hodgkin s Lymphomas Version

Non-Hodgkin s Lymphomas Version NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Non-Hodgkin s Lymphomas Version 2.2015 NCCN.org Continue Supportive Care for NHL Tumor Lysis Syndrome (TLS) Laboratory hallmarks of TLS:

More information

Lahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease

Lahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease Lahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease Faculty representative: Eva Piessens, MD, MPH Resident representative: Karen Ganz, MD Revision date: February 1, 2006

More information

Viral Hepatitis: Dr Erana Gray General and Infectious Diseases Physician

Viral Hepatitis: Dr Erana Gray General and Infectious Diseases Physician Viral Hepatitis: Dr Erana Gray General and Infectious Diseases Physician Outline: Virology HBV + pregnancy HCV + new treatments Cases Hepatitis Foundation HBV: virus HBsAg far in excess of complete virions,

More information

Katayoon Razjouyan, M.D.

Katayoon Razjouyan, M.D. Katayoon Razjouyan, M.D. Personal Information General Female Email: k_razjouyan@sbmu.ac.ir Work Address: Shahid Madani street Imam Hossein Hospital Child Psychiatry Department Occupation Child and Adolescent

More information

1114 La Revue de Santé de la Méditerranée orientale, Vol. 9, N o 5/6, 2003

1114 La Revue de Santé de la Méditerranée orientale, Vol. 9, N o 5/6, 2003 1114 La Revue de Santé de la Méditerranée orientale, Vol. 9, N o 5/6, 2003 Report The diabetes prevention and control programme of the Islamic Republic of Iran F. Azizi, 1 M.M. Gouya, 2 P. Vazirian, 2

More information

Uses and Misuses of Viral Hepatitis Testing. Origins of Liver Science

Uses and Misuses of Viral Hepatitis Testing. Origins of Liver Science Uses and Misuses of Viral Hepatitis Testing Richard S Lang, MD, MPH, FACP Chairman, Preventive Medicine Vice-Chair, Wellness Institute Raul J Seballos, MD, FACP Vice-Chair, Preventive Medicine Wellness

More information

Emerging epidemics: Will they derail progress? Eastern/Central Europe

Emerging epidemics: Will they derail progress? Eastern/Central Europe Emerging epidemics: Will they derail progress? Eastern/Central Europe Marieta Simonova, MD Clinic of Gastroenterology, Military Medical Academy Sofia, Bulgaria Disclosures Speaker/Adviser for AbbVie, Gilead,

More information

3 rd Grampian Hepatitis C Stakeholders Meeting. Pittodrie Stadium 16 th June 2011

3 rd Grampian Hepatitis C Stakeholders Meeting. Pittodrie Stadium 16 th June 2011 3 rd Grampian Hepatitis C Stakeholders Meeting Pittodrie Stadium 16 th June 2011 Grampian HCV PCR positive cases Numbers starting treatment 2011 2007 2009 2005 Grampian Hepatitis B New Diagnoses 100 90

More information

Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics

Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Hepadnaviruses Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Hepatitis viruses A group of unrelated pathogens termed hepatitis viruses cause the vast majority

More information

Dr David Rowbotham NHS. The Leeds Teaching Hospitals. NHS Trust

Dr David Rowbotham NHS. The Leeds Teaching Hospitals. NHS Trust Dr David Rowbotham The Leeds Teaching Hospitals NHS Trust NHS Nurses Update June 2010 Chronic Hepatitis HBV / HCV David Rowbotham Clinical Director & Consultant Gastroenterologist Dept of Gastroenterology

More information

Needle Stick. Mr. Fadi J. Zaben RN MSN IMET 2000, Ramallah IMET 2000

Needle Stick. Mr. Fadi J. Zaben RN MSN IMET 2000, Ramallah IMET 2000 Needle Stick Mr. Fadi J. Zaben RN MSN, Ramallah 1 Objectives: Define Needle Stick. Mention the sharps. Discus the rate of incidence. Identify the person who is at risk. Discus Needle stick and infectious

More information

ESCCMID OLL. by Author. Hepatitis in immunocompromised hosts. Treviso, July 5, Saverio G Parisi

ESCCMID OLL. by Author. Hepatitis in immunocompromised hosts. Treviso, July 5, Saverio G Parisi Hepatitis in immunocompromised hosts Treviso, July 5, 2011 Saverio G Parisi Department of Histology, Microbiology and Medical Biotechnology Università di Padova HBV Virological categories Persistent HBV

More information

Original article J Bas Res Med Sci 2017; 4(2):4-8.

Original article J Bas Res Med Sci 2017; 4(2):4-8. Prevalence of HIV, hepatitis B and C infections among volunteer blood donors at the blood transfusion center of Ilam city, Iran Hasan Boustani 1, Enayat Anvari 2, Sedighe Saiadi Sartang 2, Mehdi Omidi

More information

The Role of Liver Societies in the Global Viral Hepatitis Response

The Role of Liver Societies in the Global Viral Hepatitis Response The Role of Liver Societies in the Global Viral Hepatitis Response Anna S. Lok, MD Alice Lohrman Andrews Research Professor in Hepatology Director of Clinical Hepatology Assistant Dean for Clinical Research

More information